The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Angiotensin II–accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice
Open accessAbstract
Osteopontin (OPN) is expressed in atherosclerotic lesions, particularly in diabetic patients. To determine the role of OPN in atherogenesis, ApoE-/-OPN+/+, ApoE-/-OPN+/-, and ApoE-/-OPN-/- mice were infused with Ang II, inducing vascular OPN expression and accelerating atherosclerosis. Compared with ApoE-/-OPN+/+ mice, ApoE-/-OPN+/- and ApoE-/-OPN-/- mice developed less Ang II-accelerated atherosclerosis. ApoE-/- mice transplanted with bone marrow derived from ApoE-/-OPN-/- mice had less Ang II-induced atherosclerosis compared with animals receiving ApoE-/-OPN+/+ cells. Aortae from Ang II-infused ApoE-/-OPN-/- mice expressed less CD68, C-C-chemokine receptor 2, and VCAM-1. In response to intraperitoneal thioglycollate, recruitment of leukocytes in OPN-/- mice was impaired, and OPN-/- leukocytes exhibited decreased basal and MCP-1-directed migration. Furthermore, macrophage viability in atherosclerotic lesions from Ang II-infused ApoE-/-OPN-/- mice was decreased. Finally, Ang II-induced abdominal aortic aneurysm formation in ApoE-/-OPN-/- mice was reduced and associated with decreased MMP-2 and MMP-9 activity. These data suggest an important role for leukocyte-derived OPN in mediating Ang II-accelerated atherosclerosis and aneurysm formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management
Beckman, J. A., Creager, M. A., & Libby, P. (2002) · JAMA · doi:10.1001/jama.287.19.2570 · Cited by 2,724
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
The extracellular matrix as a cell survival factor.
Meredith, J. E., Fazeli, B., & Schwartz, M. A. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.9.953 · Cited by 1,526
Atherosclerosis is an inflammatory disease
Ross, R. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70266-8 · Cited by 1,451
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient mice
Daugherty, A., Manning, M. W., & Cassis, L. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7818 · Cited by 1,368
Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity
Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S., Rittling, S. R., Denhardt, D. T., Glimcher, M. J., & Cantor, H. (2000) · Science · doi:10.1126/science.287.5454.860 · Cited by 1,125
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
Oldberg, A., Franzén, A., & Heinegård, D. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.8819 · Cited by 1,078
Lu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017
Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)
Weber, G. F., Ashkar, S., Glimcher, M. J., & Cantor, H. (1996) · Science · doi:10.1126/science.271.5248.509 · Cited by 949
Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms
Longo, G. M., Xiong, W., Greiner, T. C., Zhao, Y., Fiotti, N., & Baxter, B. T. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215334 · Cited by 877
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
Gupta, S., Pablo, A. M., Jiang, X. C., Wang, N., Tall, A. R., & Schindler, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119465 · Cited by 868
Altered wound healing in mice lacking a functional osteopontin gene (spp1).
Liaw, L., Birk, D. E., Ballas, C. B., Whitsitt, J. S., Davidson, J. M., & Hogan, B. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2131 · Cited by 663
Gosling, J., Slaymaker, S., Gu, L., Tseng, S., Zlot, C. H., Young, S. G., Rollins, B. J., & Charo, I. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5624 · Cited by 660
Isolation and characterization of two sialoproteins present only in bone calcified matrix
Franzén, A., & Heinegård, D. (1985) · Biochemical Journal · doi:10.1042/bj2320715 · Cited by 559
The role of the renin-angiotensin system in the development of cardiovascular disease
Unger, T. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02321-9 · Cited by 515
NF-κB Mediates αvβ3 Integrin-induced Endothelial Cell Survival
Scatena, M., Almeida, M., Chaisson, M. L., Fausto, N., Nicosia, R. F., & Giachelli, C. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.1083 · Cited by 485
Macrophages and atherosclerotic plaque stability
Libby, P., Geng, Y. J., Aikawa, M., Schoenbeck, U., Mach, F., Clinton, S. K., Sukhova, G. K., & Lee, R. T. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199610000-00012 · Cited by 480
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.
Uyemura, K., Demer, L. L., Castle, S. C., Jullien, D., Berliner, J. A., Gately, M. K., Warrier, R. R., Pham, N., Fogelman, A. M., & Modlin, R. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118650 · Cited by 427
Shih, D. M., Xia, Y.-R., Wang, X.-P., Miller, E., Castellani, L. W., Subbanagounder, G., Cheroutre, H., Faull, K. F., Berliner, J. A., Witztum, J. L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910376199 · Cited by 425
Interleukin-10 Blocks Atherosclerotic Events In Vitro and In Vivo
Pinderski Oslund, L. J., Hedrick, C. C., Olvera, T., Hagenbaugh, A., Territo, M., Berliner, J. A., & Fyfe, A. I. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.12.2847 · Cited by 396
Self-citationLiaw, L., Almeida, M., Hart, C. E., Schwartz, S. M., & Giachelli, C. M. (1994) · Circulation Research · doi:10.1161/01.res.74.2.214 · Cited by 393
Collins, A. R., Meehan, W. P., Kintscher, U., Jackson, S., Wakino, S., Noh, G., Palinski, W., Hsueh, W. A., & Law, R. E. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.3.365 · Cited by 385
Self-citationChen, X.-L., Tummala, P. E., Olbrych, M. T., Alexander, R. W., & Medford, R. M. (1998) · Circulation Research · doi:10.1161/01.res.83.9.952 · Cited by 385
Giachelli, C. M., Lombardi, D. M., Johnson, R. J., Murry, C. E., & de Almeida, M. A. G. (1998) · Europe PMC (PubMed Central) · Cited by 370
Weiss, D., Kools, J. J., & Taylor, W. R. (2001) · Circulation · doi:10.1161/01.cir.103.3.448 · Cited by 368
Dependence of Cyclin E-CDK2 Kinase Activity on Cell Anchorage
Fang, F., Orend, G., Watanabe, N., Hunter, T., & Ruoslahti, E. (1996) · Science · doi:10.1126/science.271.5248.499 · Cited by 361
Osteopontin: a key cytokine in cell‐mediated and granulomatous inflammation
O'Regan, A., & Berman, J. S. (2000) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2000.00163.x · Cited by 357
Role of Osteopontin in Cellular Signaling and Toxicant Injury
Denhardt, D. T., Giachelli, C. M., & Rittling, S. R. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.723 · Cited by 349
Scavenger Receptors, Oxidized LDL, and Atherosclerosis
BOULLIER, A., BIRD, D. A., CHANG, M., DENNIS, E. A., FRIEDMAN, P., GILLOTTE‐TAYLOR, K., HÖRKKÖ, S., PALINSKI, W., QUEHENBERGER, O., SHAW, P., et al. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03943.x · Cited by 330
Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis
Ophascharoensuk, V., Giachelli, C. M., Gordon, K., Hughes, J., Pichler, R., Brown, P., Liaw, L., Schmidt, R., Shankland, S. J., Alpers, C. E., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00580.x · Cited by 293
Daugherty, A., Manning, M. W., & Cassis, L. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704331 · Cited by 289
O’Regan, A. W., Chupp, G. L., Lowry, J. A., Goetschkes, M., Mulligan, N., & Berman, J. S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.1024 · Cited by 241
Chronic Angiotensin II Infusion Promotes Atherogenesis in Low Density Lipoprotein Receptor −/− Mice
DAUGHERTY, A., & CASSIS, L. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07789.x · Cited by 209
Patarca, R., Saavedra, R. A., & Cantor, H. (1993) · PubMed · Cited by 201
Osteopontin Deficiency Attenuates Atherosclerosis in Female Apolipoprotein E–Deficient Mice
Matsui, Y., Rittling, S. R., Okamoto, H., Inobe, M., Jia, N., Shimizu, T., Akino, M., Sugawara, T., Morimoto, J., Kimura, C., et al. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000074878.29805.d0 · Cited by 196
A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis
Nau, G. J., Guilfoile, P., Chupp, G. L., Berman, J. S., Kim, S. J., Kornfeld, H., & Young, R. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6414 · Cited by 190
Osteopontin Expression in Cardiovascular Diseasesa
GIACHELLI, C. M., LIAW, L., MURRY, C. E., SCHWARTZ, S. M., & ALMEIDA, M. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44624.x · Cited by 181
Attenuated Host Resistance againstMycobacterium bovisBCG Infection in Mice Lacking Osteopontin
Nau, G. J., Liaw, L., Chupp, G. L., Berman, J. S., Hogan, B. L. M., & Young, R. A. (1999) · Infection and Immunity · doi:10.1128/iai.67.8.4223-4230.1999 · Cited by 165
Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro.
Gadeau, A., Campan, M., Millet, D., Candresse, T., & Desgranges, C. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.1.120 · Cited by 138
Kintscher, U., Goetze, S., Wakino, S., Kim, S., Nagpal, S., Chandraratna, R. A. S., Graf, K., Fleck, E., Hsueh, W. A., & Law, R. E. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00461-1 · Cited by 132
Self-citationBidder, M., Shao, J.-S., Charlton-Kachigian, N., Loewy, A. P., Semenkovich, C. F., & Towler, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206235200 · Cited by 123
Takemoto, M., Yokote, K., Nishimura, M., Shigematsu, T., Hasegawa, T., Kon, S., Uede, T., Matsumoto, T., Saitō, Y., & Mori, S. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.624 · Cited by 109
Osteopontin Transgenic Mice Fed a High-Cholesterol Diet Develop Early Fatty-Streak Lesions
Isoda, K., Kamezawa, Y., Ayaori, M., Kusuhara, M., Tada, N., & Ohsuzu, F. (2003) · Circulation · doi:10.1161/01.cir.0000055739.13639.d7 · Cited by 100
Lin, Y.-H., Huang, C., Chao, J.-R., Chen, S., Lee, S.-F., Yen, J. J.-Y., & Yang‐Yen, H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2734-2742.2000 · Cited by 96
Plutzky, J., Viberti, G. C., & Haffner, S. M. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00202-7 · Cited by 81
Tumor-derived Osteopontin Is Soluble, Not Matrix Associated
Rittling, S. R., Chen, Y., Feng, F., & Wu, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109028200 · Cited by 62
Angiotensin II Induction of Osteopontin Expression and DNA Replication in Rat Arteries
deBlois, D., Lombardi, D. M., Su, E. J., Clowes, A. W., Schwartz, S. M., & Giachelli, C. M. (1996) · Hypertension · doi:10.1161/01.hyp.28.6.1055 · Cited by 57
Katayama, Y., House, C. M., Udagawa, N., Kazama, J. J., McFarland, R. J., Martin, T. J., & Findlay, D. M. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199807)176:1<179::aid-jcp19>3.0.co;2-2 · Cited by 56
Weintraub, A. S., Schnapp, L. M., Lin, X. L., & Taubman, M. B. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780171 · Cited by 40
Bruemmer, D., Yin, F., Liu, J., Berger, J. P., Kiyono, T., Chen, J., Fleck, E., Herle, A. J. V., FORMAN, B. M., & Law, R. E. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0410 · Cited by 31
Self-citation
Cited by
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Osteopontin: role in immune regulation and stress responses
Wang, K. X., & Denhardt, D. T. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.08.001 · Cited by 669
Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease
Scatena, M., Liaw, L., & Giachelli, C. M. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.144824 · Cited by 644
The role of osteopontin in inflammatory processes
Lund, S. A., Giachelli, C. M., & Scatena, M. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0068-0 · Cited by 516
RhoA/Rho-Kinase in the Cardiovascular System
Shimokawa, H., Sunamura, S., & Satoh, K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306532 · Cited by 461
Metadata
- Authors
- Bruemmer, D., Collins, A. R., Noh, G., Wang, W., Territo, M., Arias-Magallona, S., Fishbein, M. C., Blaschke, F., Kintscher, U., Graf, K., Law, R. E., & Hsueh, W. A.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-11-01
- Volume
- 112
- Issue
- 9
- Pages
- 1318-1331
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2107843214
- Cited by
- 306
- References
- 54
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.